Aluminum Chloride

Products Aluminum chloride is available in deodorants and as a drug in solutions and as a cream. Structure and properties AlCl3 – 6H2O Effects Aluminum chloride is astringent: astringent and tanning and thus antihidrotic (antiperspirant). Indications Excessive perspiration, especially in the armpits, hands and feet. Dosage Aluminum chloride is applied to dry skin in the … Aluminum Chloride

Sublingual Immunotherapy

Products Solutions and sublingual tablets are available for sublingual immunotherapy in many countries (e.g., Oralair, Staloral, Grazax). Sublingual tablets, unlike some solutions, do not need to be stored in the refrigerator. Ingredients The medicines contain allergen extracts of common allergens, such as pollen from grasses, trees, and shrubs. Effects The allergen extracts (ATC V01AA) produce … Sublingual Immunotherapy

Piroxicam

Products Piroxicam is commercially available in tablet form (Felden, generic). It has been approved in many countries since 1986. This article refers to peroral administration. See also under piroxicam gel (off label). Structure and properties Piroxicam (C15H13N3O4S, Mr = 331.4 g/mol) exists as a white to pale yellow crystalline powder that is practically insoluble in … Piroxicam

Pimobendan

Products Pimobendan is approved for animals in the form of capsules, injectable solution, and chewable tablets. It has been approved in many countries since 1998. Structure and properties Pimobendan (C19H18N4O2, Mr = 334.4 g/mol) is a benzimidazole pyridazinone derivative. Effects Pimobendan (ATCvet QC01CE90) has vasodilator properties. The effects are due to inhibition of phosphodiesterase type … Pimobendan

Ranibizumab

Products Ranibizumab is commercially available as a solution for injection (Lucentis). The drug was approved in the United States and many countries in 2006 and in the EU in 2007. The drug’s high price is controversial, especially when compared with bevacizumab (Avastin), which is structurally and pharmacologically similar. Bevacizumab is not approved for these indications … Ranibizumab